Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers.
Fuse Biotherapeutics has raised $9.5M in total funding. The most recent round was Seed. The last funding was announced in November 2021.
Fuse Biotherapeutics's investors include Sherpa Healthcare Partners, GC&H Investments, Sirona Capital, Viva BioInnovator, Ivy Venture Group.
Fuse Biotherapeutics is headquartered in Los Angeles, United States.
Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers.
Fuse Biotherapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fuse Biotherapeutics — Funding & Investors." VCBacked, November 15, 2021, https://www.vcbacked.co/company/fuse-biotherapeutics. Accessed August 14, 2026.
VCBacked. (2021). Fuse Biotherapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/fuse-biotherapeutics
{{cite web |title=Fuse Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/fuse-biotherapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated